Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Ianelli Christopher, Chairman & CEO. Insider active across 1 company, notably iSpecimen Inc.. Cumulatively, 7 disclosures have been recorded. Activity tracked since 22 February 2022. The latest transaction was filed on 6 January 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
Christopher Ianelli is the President and CEO of iSpecimen Inc. As the leader of the company, he oversees strategic operations and ensures growth and innovation. iSpecimen Inc. specializes in the collection and distribution of biological samples. Christopher plays a key role in developing the company's vision and objectives.